Sprinklr CXM 深 滬
等待開盤 09-23 09:30:00 美东时间
5.38
-0.010
-0.19%
華盛通- 最 高5.58
- 今 開5.52
- 成交量 385.79万股
- 最 低 5.22
- 昨 收 5.39
- 總市值 124.91万
- 52周最高 8.275
- 市盈率 靜 60.59
- 換手率 1.66%
- 52周最低 4.715
- 委 比 4.76%
- 總股本 0.00亿
- 歷史最高 26.50
- 量 比 1.13
- 振 幅 6.68%
- 歷史最低 4.715
- 每 手 1
- 風險率 1.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 麦当劳目标价遭下调至320美元！现价仍有近3成上涨空间；戴尔、迈威尔、微软齐获机构看好
今日重点评级关注：HC Wainwright & Co.：维持Gossamer Bio"买入"评级，目标价从2美元升至90美元；巴克莱：维持Ultragenyx Pharmaceutical"超配"评级，目标价从32美元升至35美元
09-22 16:25
Citizens Reiterates Market Outperform on Sprinklr, Maintains $11 Price Target
Citizens analyst Patrick Walravens reiterates Sprinklr (NYSE:CXM) with a Market Outperform and maintains $11 price target.
09-21 20:54
美股周涨跌榜 | 生物医药企业SMMT周涨逾28%！关键药物取得突破；加密货币概念股齐升，IREN周内大涨26%
生物医药企业SMMT周涨逾28%！关键药物取得突破；加密货币概念股齐升，IREN周涨26%！受比特币反弹及云业务双重催化；Strive涨近25%，四天增持约1,800枚比特币>>
09-05 10:16
美股大行评级 | 大行齐上调AI应用股目标价！Adobe、CRWD等获看好，慧与科技绩后现多空分歧
今日重点评级关注：BTIG：维持Climb Bio"买入"评级，目标价从20美元升至32美元；巴克莱：维持Alpha Tau Medical"超配"评级，目标价从17美元升至30美元
09-04 12:30
Morgan Stanley Maintains Equal-Weight on Sprinklr, Raises Price Target to $8
Morgan Stanley analyst Elizabeth Porter maintains Sprinklr (NYSE:CXM) with a Equal-Weight and raises the price target from $7 to $8.
09-03 22:43
Sprinklr Q2 Adj. EPS $0.11 Beats $0.10 Estimate, Sales $213.743M Miss $214.411M Estimate
Sprinklr (NYSE:CXM) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.10 by 10 percent. This is a 15.38 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $213.743 million which missed...
09-02 19:06
Sprinklr Lowers FY2027 Adj EPS Guidance from $0.48-$0.49 to $0.47 vs $0.49 Est; Affirms FY2027 Sales Guidance of $866.500M-$868.500M vs $867.508M Est
Sprinklr (NYSE:CXM) lowers FY2027 Adj EPS guidance from $0.48-$0.49 to $0.47 vs $0.49 analyst estimate. Affirms FY2027 sales outlook from $866.500 million-$868.500 million to $866.500 million-$868.500 million vs $867.508 million estimate.
09-02 19:06
Sprinklr Sees Q3 Adj EPS $0.11 vs $0.13 Est; Sees Sales $215.000M-$216.000M vs $216.303M Est
Sprinklr (NYSE:CXM) is looking for Q3 Adj EPS of $0.11 vs $0.13 analyst estimate. sees sales of $215.000 million-$216.000 million vs $216.303 million analyst estimate.
09-02 19:05
Sprinklr Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Sprinklr, Inc. (NYSE:CXM) will release its second earnings report before the opening bell on Wednesday, Sept. 2. Analysts expect the New York-based company to report quarterly earnings of 10 cents per share, down from 13 cents per share in the year-ago period. The consensus estimate for Sprinklr’s q...
09-01 20:47
Top 3 Tech Stocks That May Collapse In Q3
As of Aug. 31, 2026, three stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days w...
08-31 20:47
